MedTrace Logo

PMCF Study of MPS-Flex® Knee System in TKA

NCT04427722 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-07-24

No results posted yet for this study

Summary

The objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available MPS-Flex® Total Knee Joint Prostheses used in primary total knee arthroplasty (TKA).

Conditions

  • Total Knee Arthroplasty

Interventions

DEVICE

MPS-Flex Total Knee Joint Prostheses

Patients who have received MPS-Flex Total Knee Joint Prostheses for their primary TKA and meet the Patient Selection Criteria outlined in the study protocol.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Zhenzhong Guo, Professor · Jizhong Erengy Fengfeng Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-25
Primary Completion
2024-08-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04427722 on ClinicalTrials.gov